FemBloc® Permanent Contraception - Early Pivotal Trial

NAActive, not recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

February 2, 2018

Primary Completion Date

January 31, 2020

Study Completion Date

July 31, 2025

Conditions
Contraception
Interventions
DEVICE

FemBloc

Treatment with FemBloc for women who desire permanent birth control (female sterilization)

PROCEDURE

Laparoscopic bilateral tubal sterilization

Laparoscopic bilateral tubal sterilization for women who desire permanent birth control (female sterilization)

Trial Locations (12)

10032

Columbia University Medical Center, New York

27612

Wake Research Associates, LLC, Raleigh

33461

Altus Research Inc., Lake Worth

37404

Chattanooga Medical Research LLC, Chattanooga

44122

University Hospitals Cleveland Medical Center, Beachwood

45069

Amy Brenner MD & Associates, Mason

46825

Women's Health Advantage, Fort Wayne

83404

Rosemark Womencare Specialists, Idaho Falls

84132

University of Utah, Salt Lake City

85224

New Horizons Clinical Trials, Chandler

94305

Stanford University, Stanford

07103

Rutgers, The State University of New Jersey, Newark

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Femasys Inc.

INDUSTRY

NCT03433911 - FemBloc® Permanent Contraception - Early Pivotal Trial | Biotech Hunter | Biotech Hunter